Ligand validation:3X07

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 3X07 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3X07_AMP_A_503	48%	44%	0.208	0.953	0.86	1.29	-	2	1	0	100%	1
3X07_AMP_A_502	41%	21%	0.212	0.926	1.88	1.43	9	4	0	0	100%	1
3X07_AMP_A_501	11%	29%	0.259	0.781	1.03	1.77	1	4	1	0	100%	1
3X05_AMP_A_502	67%	41%	0.157	0.966	0.89	1.37	1	3	0	0	100%	1
3X01_AMP_A_502	64%	43%	0.156	0.955	0.82	1.36	-	3	0	0	100%	1
3X09_AMP_A_503	58%	45%	0.176	0.955	0.89	1.22	-	2	0	0	100%	1
3X0B_AMP_A_502	51%	19%	0.188	0.942	1.95	1.49	10	2	0	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.783
4RDH_AMP_C_301	100%	23%	0.039	0.983	1.37	1.79	3	6	0	0	100%	1
3CLT_AMP_C_1262	100%	40%	0.046	0.987	0.91	1.4	1	4	0	0	100%	1
5VEO_AMP_A_524	100%	40%	0.046	0.987	0.86	1.47	-	3	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.